Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.0
-54.00%
40%
—
80.03%
60%
—
5 Years
Score4.0
Net Growth-54.00%
Net Trend40%
Net Income Consistency—
Rev Growth80.03%
Rev Trend60%
Revenue Consistency—
Intellia Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 57M to $ 67M and net income went from -$ 125M to -$ 412M. Revenue increased in 3 of those 5 years; net income in 2.
Across Intellia Therapeutics Inc's full reported history, from 2016 to 2025, revenue grew from $ 16M to $ 67M and net income went from -$ 31M to -$ 412M. Revenue increased in 70% of the years measured; net income in 20%.
Intellia Therapeutics Inc currently holds a 5-year HDB Score of 4.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 12.09 | — |
1 Year2025-08-12 | $ 10.86 | 11.33% |
5 Years2021-08-12 | $ 160.28 | -92.46% |
10 Years2016-08-12 | $ 18.34 | -34.08% |
All Time2016-05-06 | $ 22.10 | -45.29% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2016-05-06 |
|---|---|---|---|---|---|
| Price | $ 12.09 | $ 10.86 | $ 160.28 | $ 18.34 | $ 22.10 |
| Return | — | 11.33% | -92.46% | -34.08% | -45.29% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 59M | -$ 399M | $ 437M |
| 2025 | $ 67M | -$ 412M | $ 449M |
| 2024 | $ 57M | -$ 519M | $ 601M |
| 2023 | $ 36M | -$ 481M | $ 912M |
| 2022 | $ 52M | -$ 474M | $ 1.19B |
| 2021 | $ 33M | -$ 259M | $ 748M |
| 2020 | $ 57M | -$ 125M | $ 597M |
| 2019 | $ 43M | -$ 99M | $ 279M |
| 2018 | $ 30M | -$ 85M | $ 314M |
| 2017 | $ 26M | -$ 67M | $ 340M |
| IPO2016 | $ 16M | -$ 31M | $ 273M |
Explore beyond NTLA
You're looking at Intellia Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
